These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19604232)

  • 1. Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women.
    Siegerink B; Algra A; Rosendaal FR
    Br J Haematol; 2009 Aug; 146(4):459-61. PubMed ID: 19604232
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
    Hernández-Romero D; Marín F; Lee KW; Roldán V; Caturla J; Corral J; Valdés M; Lip GY; Vicente V; González-Conejero R
    Thromb Haemost; 2010 Sep; 104(3):650-2. PubMed ID: 20589311
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of factor XIII VAL34LEU polymorphism on thrombolytic therapy in premature myocardial infarction.
    Roldán V; Corral J; Marín F; Rivera J; Vicente V
    Thromb Haemost; 2002 Aug; 88(2):354-5. PubMed ID: 12195711
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
    Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
    Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-I gene variants and risk of myocardial infarction.
    Marian AJ
    Curr Atheroscler Rep; 2006 May; 8(3):174-6. PubMed ID: 16767840
    [No Abstract]   [Full Text] [Related]  

  • 7. Prothrombotic gene variation in patients with large and small vessel disease.
    Pruissen DM; Kappelle LJ; Rosendaal FR; Algra A;
    Neuroepidemiology; 2008; 31(2):89-92. PubMed ID: 18622144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.
    Ambroziak M; Kuryłowicz A; Budaj A
    J Thromb Thrombolysis; 2019 Oct; 48(3):519-527. PubMed ID: 30972713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.
    Reiner AP; Heckbert SR; Vos HL; Ariëns RA; Lemaitre RN; Smith NL; Lumley T; Rea TD; Hindorff LA; Schellenbaum GD; Rosendaal FR; Siscovick DS; Psaty BM
    Blood; 2003 Jul; 102(1):25-30. PubMed ID: 12456499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation factor XIII B subunit antigen, FXIIIVal34Leu genotype and ischaemic stroke in South Asians.
    Kain K; Young J; Bavington J; Bamford J; Catto AJ
    Thromb Haemost; 2005 Feb; 93(2):394-5. PubMed ID: 15711767
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.
    Roldán V; Corral J; Marín F; Rivera J; Pineda J; González-Conejero R; Sogorb F; Vicente V
    Am J Cardiol; 2003 May; 91(10):1242-5. PubMed ID: 12745111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor XIII Val34Leu polymorphism and premature myocardial infarction].
    Marín F; Roldán V; Sogor F
    Rev Esp Cardiol; 2002 Oct; 55(10):1106-7. PubMed ID: 12383402
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women.
    Reiner AP; Frank MB; Schwartz SM; Linenberger ML; Longstreth WT; Teramura G; Rosendaal FR; Psaty BM; Siscovick DS
    Br J Haematol; 2002 Feb; 116(2):376-82. PubMed ID: 11841441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two factor XIII gene polymorphisms associated with a structural and functional defect and the risk of myocardial infarction in men.
    Doggen CJ; Reiner AP; Vos HL; Rosendaal FR
    J Thromb Haemost; 2003 Sep; 1(9):2056-8. PubMed ID: 12941053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Six case-control studies from the Osterbro-study (The Copenhagen City Heart Study). Angiotensinogen mutations and risk of myocardial and cerebral ischemia].
    Sethi AA; Tybjaerg-Hansen A; Grønhold ML; Steffensen R; Schnohr P; Nordestgaard BG
    Lakartidningen; 2002 May; 99(21):2392-3. PubMed ID: 12090166
    [No Abstract]   [Full Text] [Related]  

  • 16. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults.
    Pezzini A; Grassi M; Del Zotto E; Lodigiani C; Ferrazzi P; Spalloni A; Patella R; Giossi A; Volonghi I; Iacoviello L; Magoni M; Rota LL; Rasura M; Padovani A
    Neurology; 2009 Sep; 73(9):717-23. PubMed ID: 19720979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor XIII Tyr204Phe gene variant and the risk of ischemic stroke.
    Landau MB; Renni MS; Zalis MG; Spector N; Gadelha T
    J Thromb Haemost; 2013 Jul; 11(7):1426-7. PubMed ID: 23601743
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene polymorphisms and the risk of myocardial infarction--an emerging relation.
    Peters RJ; Boekholdt SM
    N Engl J Med; 2002 Dec; 347(24):1963-5. PubMed ID: 12477948
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke.
    Pruissen DM; Slooter AJ; Rosendaal FR; van der Graaf Y; Algra A
    Blood; 2008 Feb; 111(3):1282-6. PubMed ID: 18006701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction.
    Elmas E; Ahmad-Nejad P; Weiss C; Neumaier M; Borggrefe M
    Clin Chem Lab Med; 2008; 46(9):1329-31. PubMed ID: 18785870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.